Associated Papers
NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity.
Moecking J et al.
The Journal of Allergy and Clinical Immunology, 2021
Impact of rare and common genetic variation in the interleukin-1 pathway on human cytokine responses.
van Deuren RC et al.
Genome Medicine, 2021
34034819 (PubMed )
Supplement: 13073_2021_907_MOESM1_ESM.xlsx › Table_S3
Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Somatic Mutations in CDH1 and Other Clinically Actionable Mutations Imply Early Use of Targeted Agents.
Wang LC et al.
Current Oncology (toronto, Ont.), 2021
NGS study of glucocorticoid response genes in inflammatory bowel disease patients.
Skrzypczak-Zielinska M et al.
Archives of Medical Science : Ams, 2021
NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome.
Levandowski CB et al.
Proceedings of the National Academy of Sciences of the United States of America, 2013
The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model.
Aksentijevich I et al.
Arthritis and Rheumatism, 2007
Select a paper to view details